Array-based analysis of gene expression in childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 28, Issue 1, 2004, Pages 1-7

  Bruchova, Hana ^a   Kalinova, Marketa ^b   Brdicka, Radim ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atlas Human Cancer cDNA Arrays (Clontech); Childhood ALL; Gene expression analyses

Indexed keywords

PROTEIN; PROTEIN B JUN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; CANCER DIAGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; LEUKOCYTE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ISOLATION; UNINDEXED SEQUENCE; UPREGULATION;

EID: 0242636618     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00120-6     Document Type: Article

References (31)

1. Fink F.M., Gadner H. Acute leukemia in childhood. Wien Med Wochenschr. 141:1991;190-195.
2. McCauley D.L. Treatment of adult acute leukemia. Clin Pharm. 11:1992;767-796.
3. Bruchova H., Borovanova T., Klamova H., Brdicka R. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk Lymphoma. 43:2002;1289-1295.
4. Armstrong S.A., Staunton J.E., Silverman L.B., Pieters R., den Boer M.L., Minden M.D., et al. MLL translocation specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 30:2002;41-47.
5. Ohmine K., Ota J., Ueda M., Ueno S., Yoshida K., et al. Characterization of stage progression on chronic myeloid leukemia by DNA microarays with purified hematopoietic stem cells. Oncogene. 20:2001;8249-8257.
6. Cohen N., Rozenfeld-Granot G., Hardan I., Brok-Simoni F., Amariglio N., Rechavi G., et al. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet. 128:2001;114-119.
7. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537.
8. Yeoh E.J., Ross M.E., Shurteff S.A., Williams W.K., Patel D., Mahfouz R., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:2002;133-143.
9. Chomczynsky P., Sacchi N. Single step method of RNA isolation by acid quanidin-isothiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
10. de Azevedo W.F. Jr., Canduri F., da Silveira N.J. Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. Biochem Biophys Res Commun. 293:2002;566-571.
11. Jena N., Deng M., Sicinska E., Sicinski P., Daley G.Q. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. Cancer Res. 62:2002;535-541.
12. Wolowiec D., Ciszak L., Kosmaczewska A., Bocko D., Teodorowska R., Frydecka I., et al. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica. 86:2001;1296-1304.
13. Delmer A., Ajchenbaum-Cymbalista F., Tang R., Ramond S., Faussat A.M., Marie J.P., et al. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood. 85:1995;2870-2876.
14. Del Giglio A., O'Brien S., Ford R.J. Jr., Manning J., Saya H., Keating M., et al. Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL). Leuk Lymphoma. 10:1993;265-271.
15. O'Reilly P.E., Raab S.S., Niemann T.H., Rodgers J.R., Robinson R.A. p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas. Mod Pathol. 10:1997;91-97.
16. Ball L.M., Pope J., Howard C.V., Eccles P., van Velzen D. PCNA Ki-67 dissociation in childhood acute lymphoblastic leukaemia. An immunofluorescent laser confocal scanning microscopical study. Cell Biol Int. 18:1994;869-874.
17. Tourret J., McKeon F. Tyrosine kinases wee1 and mik1 as effectors of DNA replication checkpoint control. Prog Cell Cycle Res. 2:1996;91-97.
18. D'Sa-Eipper C., Subramanian T., Chinnadurai G. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 56:1996;3879-3882.
19. Schedel J., Gay R.E., Kuenzler P., Seemayer C., Simmen B., Michel B.A., et al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum. 46:2002;1512-1518.
20. Cheng G., Cleary A.M., Ye Z.S., Hong D.I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1995;1494-1498.
21. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
22. Patel M., Faulkner L., Katz D.R., Brickell P.M. The c-fgr proto-oncogene: expression in Epstein-Barr-virus-infected B lymphocytes and in cells of the myelomonocytic and granulocytic lineages. Patel Pathobiol. 59:1991;289-292.
23. Hofmann W.K., de Vos S., Elashoff D., Gschaidmeier H., Hoelzer D., Koeffler H.P., et al. Relation between resistance of Philadelphia-chromosome- positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet. 359:2002;481-486.
24. Waage A., Espevik T. TNF receptors in chronic lymphocytic leukemia. Leuk Lymphoma. 13:1994;41-46.
25. Vinante F., Rigo A., Tecchio C., Morosato L., Nadali G., Ricetti M.M., et al. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome. Br J Haematol. 102:1998;1025-1034.
26. Sharma R.P., Kim Y.W. Localization of retinoic acid receptors in anterior-human embryo. Exp Mol Pathol. 62:1995;180-189.
27. Turner C.E. Paxillin. Int J Biochem Cell Biol. 30:1998;955-959.
28. Beckerle M.C. Zyxin: zinc fingers at sites of cell adhesion. Bioessays. 19:1997;949-957.
29. Macalma T., Otte J., Hensler M.E., Bockholt S.M., Louis H.A., Kalff-Suske M., et al. Molecular characterization of human zyxin. J Biol Chem. 271:1996;31470-31478.
30. Renard N., Duvert V., Banchereau J., Saeland S. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood. 84:1994;2253-2260.
31. Cao L.X., Le Bousse-Kerdiles M.C., Clay D., Oshevski S., Jasmin C., Krief P. Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation. Blood. 89:1997;3615-3623.